Anti-Serpin-B8 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of mature human Serpin-B8 (P50452); validated for WB.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
P50452
Size
100ug
Cat. #
RP2SerpinB8

In stock

SKU
RP-SerpinB8

Options

As low as: $130.00

Target Overview

Serpin-B8 (UniProt P50452), also known as cytoplasmic antiproteinase 2 (CAP-2) or peptidase inhibitor 8 (PI-8), is a 374-residue member of the ov-serpin (clade B) family of intracellular serine protease inhibitors. Unlike the secreted serpins, clade B members lack a cleavable signal peptide and accumulate in the cytoplasm, where Serpin-B8 has been documented to participate in epithelial desmosome-mediated cell-cell adhesion. The reactive center loop of Serpin-B8 contains a basic P1 residue, consistent with inhibitory activity against trypsin-like and furin-like proprotein convertases; PI-8 has been characterized biochemically as an inhibitor of furin and related PCs in cell-based assays. Expression has been reported in a broad range of epithelial tissues, with notable signal in skin, placenta, and pancreas, and the protein is also detected in hematopoietic cells. Researchers working on serpin biology examine Serpin-B8 for its contribution to desmosomal integrity, its potential to restrict furin-dependent maturation of host and pathogen substrates, and its dysregulation in tumor and fibrotic contexts. The two TPB SKUs in this family (RP1SerpinB8, RP2SerpinB8) were both raised in rabbit against the amino end of the mature protein, giving epitope coverage in a region distinct from the C-terminal reactive center loop and minimizing recognition of cleaved/complexed serpin species in the same way that RCL-directed reagents would. Reactivity has been validated against human Serpin-B8; reactivity in mouse, rat, dog, and non-human primate is predicted on the basis of sequence homology and has not been formally confirmed.

Background

Serpin-B8 belongs to the ov-serpin subfamily that also includes SerpinB3/SCCA1, SerpinB4/SCCA2, SerpinB5/maspin, SerpinB6/PI-6, and SerpinB9/PI-9. These intracellular serpins use the canonical serpin suicide-substrate mechanism, in which cleavage of the reactive center loop by a target protease drives a large conformational change that traps the protease in a covalent acyl-enzyme complex. The P1-P1' residues of Serpin-B8 (Arg-Cys) point to basic-specific proteases as physiological targets, and direct evidence has accumulated for furin as one such target. The role of Serpin-B8 in furin inhibition has clear pathogen-relevant consequences. Petersen et al. (2023, J Virol) showed that rerouting Serpin-B8 to the secretory pathway, where furin processes the HIV-1 envelope precursor gp160 to gp120/gp41, suppresses production of infectious HIV-1 particles. This work positions endogenous Serpin-B8 localization as a determinant of which furin substrates are protected from cleavage, and motivates examination of Serpin-B8 expression in cells supporting viruses that depend on PC-mediated glycoprotein maturation. Serpin-B8 has also surfaced in several disease-association studies. The gene was reported among loci implicated in familial pulmonary fibrosis (Liu et al., 2023, Am J Respir Crit Care Med), and altered methylation at SERPINB8 has been described in matched primary and metastatic melanoma samples (Ouwerkerk et al., 2025, Hum Genomics). Transcriptomic surveys have flagged SERPINB8 expression changes in testicular tissue from men with nonobstructive azoospermia (Hashemi Karoii et al., 2023), and Tsiftsoglou (2025) catalogued Serpin-B8 among intracellular heme-binding proteins carrying pathology-associated polymorphisms at predicted heme-coordinating residues. Researchers interested in epithelial adhesion, host-pathogen interactions at the level of furin biology, or serpin involvement in fibrotic and oncologic processes will find Serpin-B8 a useful target for both expression analysis (WB).

References

  1. Ouwerkerk J et al (2025) Genome-wide methylation profiles of primary and matched distant metastasis: insights from the Dutch Early-Stage melanoma (D-ESMEL) study. Hum Genomics. PubMed · DOI.
  2. Tsiftsoglou SA (2025) Multiple classes of human intracellular Heme-binding proteins with pathology-associated polymorphisms of heme coordinating residues. Biochim Biophys Acta Mol Basis Dis. PubMed · DOI.
  3. Hashemi Karoii D et al (2023) Altered G-Protein Transduction Protein Gene Expression in the Testis of Infertile Patients with Nonobstructive Azoospermia. DNA Cell Biol. PubMed · DOI.
  4. Petersen M et al (2023) Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8. J Virol. PubMed · DOI.
  5. Liu Q et al (2023) The Genetic Landscape of Familial Pulmonary Fibrosis. Am J Respir Crit Care Med. PubMed · DOI.

Additional Specifications

Gene Symbol SerpinB8
UniProt ID P50452
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Amino end mature Serpin-B8)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Reactive Center Loop (RCL))Immunogen is proprietary and confidential. Immunogen generated in amino acid region 329-369.
Alternate Names SERPINB8, Serpin B8, Cytoplasmic antiproteinase 2, CAP-2, CAP2, Peptidase inhibitor 8, PI-8, PI8

Frequently Asked Questions

What molecular weight should I expect for Serpin-B8 on a Western blot?

Serpin-B8 (PI-8) migrates at approximately 42–45 kDa on reducing SDS-PAGE, consistent with its 374-residue predicted mass of roughly 42.8 kDa. Because Serpin-B8 is an intracellular serpin lacking a signal peptide and significant post-translational glycosylation, the observed band usually tracks close to the calculated molecular weight. Minor gel-shift variability can occur depending on lysate oxidation state or protease cleavage during sample preparation. Using fresh lysate with a cocktail of protease inhibitors will yield the sharpest band at the expected size.

Which tissue or cell lysates serve as good positive controls for Serpin-B8?

Serpin-B8 is broadly expressed in epithelial tissues, with particularly strong signal reported in skin keratinocytes, placenta, and stratified squamous epithelia. For validation, human keratinocyte lines such as HaCaT or primary epidermal keratinocyte lysates are reliable positive controls. Placental tissue lysate is another high-expressing source. Non-epithelial lines such as lymphoid or fibroblast cultures typically show lower or undetectable Serpin-B8, making them useful negative or low-expression comparators. Confirm expression in your specific cell model by RT-PCR or publicly available RNA-seq datasets before troubleshooting antibody performance.

What starting dilution should I use for Western blot with this Serpin-B8 antibody?

We recommend starting at 1:1000 dilution for Western blot, based on our internal validation in human epithelial lysates. This polyclonal rabbit antibody was raised against a broad immunogen spanning Serpin-B8 residues, so epitope accessibility is typically good under standard denaturing conditions. If your lysate has low Serpin-B8 expression or if background is minimal after the first trial, you can increase concentration to 1:500. Conversely, if non-specific bands appear, dilute further to 1:2000. Always include a no-primary control to distinguish true signal from secondary-antibody artifacts.

Does Serpin-B8 form complexes with proteases that change the Western blot pattern?

Yes. Serpin-B8 functions as a suicide-substrate inhibitor that forms stable, covalent SDS-resistant complexes with target serine proteases such as furin. These serpin–protease complexes migrate at higher apparent molecular weights—typically 80–120 kDa depending on the protease—and can appear as additional bands above the 42–45 kDa monomer. The ratio of monomer to complex varies with cellular protease activity and stress state. If you observe high-molecular-weight smearing or discrete upper bands, consider treating lysate with reducing agent and boiling to maximize monomer recovery, though some complexes remain stable even under denaturing conditions.

Is this Serpin-B8 antibody cross-reactive with mouse or rat samples?

Human reactivity is validated; mouse and rat cross-reactivity are predicted but not yet confirmed in-house. Serpin-B8 shares approximately 70–75 percent sequence identity between human and rodent orthologs, with conserved epitopes in the core serpin domain. Researchers have reported variable success using human-Serpin-B8 antibodies on mouse tissue, often requiring optimization of dilution and fixation for immunohistochemistry. We recommend pilot Western blots on mouse or rat epithelial lysates at 1:500 and 1:1000 to assess signal strength and specificity before committing to larger experiments. Include a validated human control in parallel.

Can I use this antibody for immunofluorescence on fixed keratinocytes?

Yes, Triple Point Biologics antibodies are validated for immunofluorescence as well as Western blot and IHC. For Serpin-B8 immunofluorescence in cultured keratinocytes, fix cells in four percent paraformaldehyde, permeabilize with 0.1–0.2 percent Triton X-100, and start antibody dilution at 1:100 to 1:200. Because Serpin-B8 is cytoplasmic and enriched at desmosomes, you should observe diffuse cytosolic staining with focal concentration at cell–cell junctions. Co-staining with desmosomal markers such as desmoplakin can confirm localization. Optimize blocking and wash steps to minimize background in your specific fixation protocol.

How should I store this Serpin-B8 antibody and how long does it remain stable?

Store the antibody at –20 °C in small aliquots to avoid repeated freeze–thaw cycles, which can reduce titer and increase aggregation. The polyclonal is supplied in a stabilizing buffer; once thawed, an aliquot can be held at 4 °C for up to one month for routine use. Do not store diluted working solutions; prepare fresh in blocking buffer for each experiment. Under these conditions, the antibody retains reactivity for at least two years from receipt. If you observe declining signal or increased background over time, prepare a fresh aliquot and re-optimize dilution.

What is the biological role of Serpin-B8 and why does expression vary across my samples?

Serpin-B8 is an intracellular inhibitor of furin and related proprotein convertases, implicated in regulating desmosome-mediated cell adhesion and epithelial integrity. Expression is highest in stratified squamous epithelia—skin, oral mucosa, esophagus—and is inducible by differentiation signals, cytokines, and cellular stress. Variability across your samples likely reflects differences in epithelial differentiation state, confluence, or inflammatory milieu. For instance, subconfluent or proliferating keratinocytes may show lower Serpin-B8 than differentiated, contact-inhibited cultures. Normalizing culture conditions or tracking differentiation markers alongside Serpin-B8 can clarify sample-to-sample variation.

Western blot validation for RP-SerpinB8 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Serpin-B8: Amino end mature Serpin-B8 — WB validation
WB · Panel 1 Serpin-B8: Amino end mature Serpin-B8

Custom validation studies available on request — contact us.

Also known as:

  • SERPINB8
  • Serpin B8
  • Cytoplasmic antiproteinase 2
  • CAP-2
  • CAP2
  • Peptidase inhibitor 8
  • PI-8
  • PI8
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →